Professor HYWEL WILLIAMS HYWEL.WILLIAMS@NOTTINGHAM.AC.UK
PROFESSOR OF DERMATO-EPIDEMIOLOGY
Atopic eczema affects many adults and up to 20% of children,1 with health costs comparable to diabetes2 and asthma.3 One community survey of 1760 young children in the United Kingdom found that 84% had mild eczema, 14% moderate, and 2% severe eczema.4 Topical corticosteroids are a mainstay of treatment for inflammatory episodes.5 Most long established topical corticosteroids such as betamethasone valerate
or hydrocortisone are applied at least twice daily, but three newer preparations (mometasone, fluticasone,
and methylprednisolone) have been developed
for once daily application. Here, I propose that established preparations need be applied only once daily.
Williams, H. C. (2007). Established corticosteroid creams should be applied only once daily in patients with atopic eczema. British medical journal, 334,
Journal Article Type | Article |
---|---|
Publication Date | Jun 16, 2007 |
Deposit Date | Mar 20, 2008 |
Publicly Available Date | Mar 20, 2008 |
Journal | British Medical Journal |
Print ISSN | 0007-1447 |
Peer Reviewed | Peer Reviewed |
Volume | 334 |
Public URL | https://nottingham-repository.worktribe.com/output/704148 |
Related Public URLs | http://www.bmj.com/ |
once_daily_TCS.pdf
(269 Kb)
PDF
Topical anti-inflammatory treatments for eczema: network meta-analysis
(2024)
Journal Article
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
Apache License Version 2.0 (http://www.apache.org/licenses/)
Apache License Version 2.0 (http://www.apache.org/licenses/)
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search